SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-16-000254
Filing Date
2016-10-17
Accepted
2016-10-17 15:00:58
Documents
50
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 482008
2 exhibit10-1.htm EX-10.1 200642
3 exhibit10-2.htm EX-10.2 23579
4 exhibit31.htm EX-31 17681
5 exhibit32-1.htm EX-32.1 7646
  Complete submission text file 0001424884-16-000254.txt   2107832

Data Files

Seq Description Document Type Size
6 qbio-20160831.xml EX-101.INS 238414
7 qbio-20160831.xsd EX-101.SCH 22071
8 qbio-20160831_cal.xml EX-101.CAL 29427
9 qbio-20160831_def.xml EX-101.DEF 48020
10 qbio-20160831_lab.xml EX-101.LAB 160760
11 qbio-20160831_pre.xml EX-101.PRE 124646
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 161938768
SIC: 2834 Pharmaceutical Preparations